DCF — S.E. REGL MEDICAL CENTER
Enterprise Value: $-263.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-263.7M
Enterprise Value
$-88.2M
PV of Cash Flows
$-175.5M
PV of Terminal Value
$-282.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $307.1M | $-13.8M | -4.0% | $-26.8M | $-24.4M |
| Year 2 | $316.3M | $-11.1M | -3.0% | $-24.5M | $-20.2M |
| Year 3 | $325.8M | $-8.1M | -2.0% | $-21.9M | $-16.5M |
| Year 4 | $335.6M | $-6.7M | -2.0% | $-20.9M | $-14.3M |
| Year 5 | $345.6M | $-6.0M | -2.0% | $-20.7M | $-12.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-263.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$298.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.049999998826039074
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5